Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524604 | NSE Symbol : | ISIN : INE276T01018 | Industry : Pharmaceuticals - Indian - Formulations |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
02-May-2025	09-May-2025	Accounts	Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2025 inter alia to consider and approve 1. The Audited Financial Statements and Financial Results of the Company for the quarter and year ended March 31 2025 and 2. Any other business with the permission of Chair. Outcome of Board Meeting held today i.e., Friday, 9th May, 2025 at Registered Office of the Company has inter alia considered and approved the following businesses : (1)Audited Financial Results along with Audit Report of the Company for the Quarter and Financial year ended 31st March, 2025. (2) Appointment of M/s. Rahul Doshi & Co, Chartered Accountants (FRN:150982W, Membership No: 117160) as Internal Auditor of the Company for the Financial Year 2025-26. (3)Appointment of M/s Jitendra Parmar & Associates, Practicing Company Secretaries(FRN: S2023GJ903900, Membership No: F11336, COP No.: 15863) as Secretarial Auditor of the Company for the Financial Year2024-25 and (4) Resignation of Mrs. Ritu Singh as Company Secretary of the Company w.e.f. 22nd April, 2025 (As Per BSE Announcement Dated on :09.05.2025)
09-Apr-2025	12-Apr-2025	Change in Directors	Inter alia, to consider and approve the Appointment of Mr. Vrushank Balkrushna Patel (DIN: 05310613), and Mr. Nilay Jitendrabhai Vaghasiya (DIN: 08050673) as Additional Directors (Non-Executive - Non Independent) on the Board of the Company with effect from 12.04.2025. Outcome of Board Meeting held on 12th April, 2025 for the appointment of Additional Director on the Board of Directors of the Company under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated on: 12/04/2025)
25-Jan-2025	04-Feb-2025	Quarterly Results	Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 inter alia to consider and approve 1) Unaudited Financial Results along with Limited Review Report for the Quarter & Nine months ended December 31 2024; 2) Any other business with the permission of the Chair. Outcome of the Board Meeting held on 4th February, 2025 and has considered and approved Unaudited Financial Results for the Quarter and Nine Months ended on 31st December, 2024. (As per BSE Announcement Dated on 04/02/2025)
04-Dec-2024	11-Dec-2024	Change in Directors	Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2024 inter alia to consider and approve 1) To Analyze and approve the request received for Reclassification of Shareholding from 'Promoter/Promoter Group' to 'Public' Category. 2) To appoint Dhawal Akhilesh Deopura (DIN: 09509762) as Additional Non-Executive Independent Director 2) Any other business with the permission of the Chair. Pursuant to Regulation 30 of the SEBI (LODR) Regulations, we wish to inform that Board of Directors in their meeting held today i.e., 11/12/2024 has approved the agendas as listed in the Outcome of Board Meeting. We are submitting herewith Extract of the Minutes of the Board Meeting held today i.e., 11th December, 2024 at 04:00 P.M. at Registered Office of the Company. (As per BSE Announcement Dated on 11/12/2024)
22-Oct-2024	13-Nov-2024	Quarterly Results	Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve We hereby inform you that Meeting of Board of Directors is scheduled to be held on Tuesday 29th October 2024 at 3:00 PM at Registered Office of the Company. Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve 1) To consider approval of Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2024. 2) Any other business with the permission of the Chairman. (As Per BSE Announcement Dated on: 26/11/2024) Outcome of Board Meeting to be held on Wednesday, 13th September, 2024 at Registered Office of the Company to discuss on agendas as per attached Outcome of Meeting. Results for Financial Results for Quarter and Half Year ended 30h September, 2024. (As per BSE Announcement Dated on 13/11/2024)
16-Aug-2024	24-Aug-2024	AGM	Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2024 inter alia to consider and approve This is to inform that a Meeting of Board of Directors of the Company scheduled to be held on Saturday 24th August 2024 at Registered office of the Company to discuss AGM Related Agendas. Outcome of Board Meeting held on 24th August, 2024 and Disclosure under Regulation 30 of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 ('Listing Regulations') (As Per BSE Announcement dated on 24.08.2024)
08-Jul-2024	15-Jul-2024	Quarterly Results	Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/07/2024 inter alia to consider and approve This is to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday 15th July 2024 at the Registered office of the Company to transact businesses as mentioned in the Intimation of Board Meeting. Outcome of the Board Meeting held on 15.07.2024 for Unaudited Financial Results for the quarter ended 30th June, 2024 (As Per BSE Announcement dated on 15.07.2024)
14-May-2024	23-May-2024	Accounts	Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 inter alia to consider and approve To consider approval of Audited FInancial Results for the Quarter and Year ended March 2024 Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations''), we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Thursday, May 23, 2024 at Registered Office of the Company situated at 403, Sarthik II, Opp. Rajpath Club, S.G. Highway, Bodakdev, Ahmedabad- 380054, Gujarat, India, has inter alia considered and approved Audited Financial Results along with Audit Report of the Company for the Quarter and Financial Year ended on 31st March, 2024 Pursuant to Regulation 30 and 33 of SEBI(LODR) Regulation, 2015, Board has approved Financial Results for Quarter and Year ended March, 2024. (As per BSE Announcement Dated on 23/05/2024) Clarification Letter for clerical and typographical error in the Annexure A (Financial Results filed for Quarter Ended 31st March, 2024). Disclosure under Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 This is to inform you that that we hereby rectified the following discrepancies: 1) EPS figures in Financial Results for the Quarter and Financial Year ended on 31st March, 2024; 2) Declaration regarding Audit report with unmodified opinion with respect to Annual Audited Financial Results for the Financial Year ended 31st March, 2024 (Annexure- B). (As Per BSE Announcement Dated on 25.06.2024)
05-Mar-2024	05-Mar-2024	Change in Directors	The Board of Directors of the Company at its meeting held today i.e. March 05th, 2024 (started at 02:30 P.M. and concluded at 03:00 P.M.) inter-alia considered and approved the following: Upon the recommendation of Nomination and Remuneration committee, considered and approved the appointment of Mr. Sarang Pathak as a Managing Director of the Company for a period of five years effective on March 05th, 2024. The detailed disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 The resignation of Mr. Vikas Patel who will cease to be the Chief Financial Officer (CFO) of the Company w.e.f. closure of business hours on March 05, 2024; and approved the appointment of Mr. Kuldip Parekh as the Chief Financial Officer of the Company w.e.f. March 05, 2024.The detailed disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 The Board has in its meeting held today i.e.: 05.03.2024, has considered and took the note of the resignation of Mr. Vikas Patel, Chief Financial Officer of the Company w.e.f. 05.03.2024. Also, board has in its meeting held today i.e.: 05.03.2024 on the reccomendation of Nomination & remuneration committee has appointed Mr. Kuldip Parekh as the Chief Financial Officer of the Company.
03-Feb-2024	03-Feb-2024	Change in Auditors	Relating to noting of Acquisition of shares pursuant to open offer, change in Directors and KMPs and change in constitution of committees and change in Registered office address and email address of Company. Appointment of Mrs. Ritu Singh qualified Company Secretary as Company secretary and Compliance officer of the Company. Resignation of Directors of the Company in view of change in management pursuant to open offer. Change in registered office address. Change in Directors of the Company Pursuant to successful takeover activities and transition in management- Resignation of Chairman and Independent Director of the Company Resignation of CFO Resignation of Directors including Independent Directors Appointment of CFO
16-Jan-2024	25-Jan-2024	Quarterly Results	Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended on 31st December 2023. We are enclosing herewith copy of the Unaudited Financial Results for the quarter ended on 31st December, 2023 along with Limited Review Report thereon. This is as per Regulation - 33 of the SEBI (LODR) Regulations, 2015 Submitting herewith Financial Results For Quarter Ended on 31st December, 2023. (As per BSE Announcement Dated on 25/01/2024)
30-Oct-2023	08-Nov-2023	Quarterly Results	Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended on 30th September 2023. Please note that the Board of Directors in their meeting held today, have taken on record the Unaudited Financial Results for the quarter ended on 30th September, 2023. We are enclosing herewith copy of the said Unaudited Financial Results and Limited Review Report thereon. Submitting herewith Unaudited Financial Results for quarter ended on 30th September, 2023 along with Limited Review report. (As Per BSE Announcement Dated on 08/11/2023)
02-Aug-2023	14-Aug-2023	Quarterly Results	Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve Unaudited Financial Results For The Quarter Ended On 30Th June 2023. The Board of Directors in their meeting held today, have taken on record the Unaudited Financial Results for the quarter ended on 30th June, 2023. We are enclosing herewith copy of the said Unaudited Financial Results for the quarter ended 30th June, 2023 along with Limited Review Report thereon. (As Per BSE Announcement dated on 14.08.2023)
18-Jul-2023	18-Jul-2023	AGM	The Board of Directors in their meeting held today have decided to convene Annual General Meeting of the Company on Wednesday, the 20th September, 2023 at 12.00 Noon through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). The Board of Directors in their meeting held today have fixed book closure for the 35th AGM of the Company. The Board of Directors in their meeting held today have decided to convene Annual General Meeting of the company on Wednesday the 20th September, 2023 at 12.00 noon through Video Conferencing (VC)/ Other Audio visual means (OAVM).
16-May-2023	30-May-2023	Accounts	Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve the Standalone Audited Financial Results of the Company for the Financial Year 2022 23 ended on 31st March 2023 Quarterly Results & Audited Results (As Per BSE Bulletin dated on 16.05.2023) Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we are enclosing herewith: 1. Statement of Audited Financial Results for the year ended on 31st March, 2023. 2. Auditors' Report on the Audited Financial Results 3. Declaration to the effect that there is Unmodified Opinion with respect to Audited Financial Results for the year ended on 31st March, 2023 Please note that the Board of Directors in their meeting held today i.e. on 30th May, 2023, have approved the Audited Financial Results for the financial year 2022-23 ended on 31st March, 2023. Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we are enclosing herewith: 1. Statement of Audited Financial Results for the year ended on 31st March, 2023. 2. Auditors' Report on the Audited Financial Results 3. Declaration to the effect that there is Unmodified Opinion with respect to Audited Financial Results for the year ended on 31st March, 2023 (As Per BSE Announcement dated on 30.05.2023)

1 2

LOGIN HERE

Adline Chem Lab Ltd

Board Meeting